Protriptyline hydrochloride

Protriptyline hydrochloride (CAS No.: 1225-55-4) is a synthetic small molecule and the hydrochloride salt form of the tricyclic secondary amine protriptyline, broadly classified within the tricyclic antidepressant research class and used as a pharmacological tool in neurobiology and central nervous system drug discovery to interrogate monoaminergic and cholinergic signaling biology; mechanistically, it is characterized by inhibition of norepinephrine and serotonin reuptake at presynaptic nerve terminals, leading to increased extracellular monoamine availability, and it has also been reported to exhibit anticholinergic activity, acetylcholinesterase inhibitory effects, and modulation of amyloid beta self assembly in experimental systems, supporting its relevance to studies of neurotransmitter homeostasis, synaptic transmission, and neurodegeneration related pathways; available in vitro evidence indicates activity in the micromolar domain for acetylcholinesterase inhibition, while transporter and receptor associated pharmacology is commonly evaluated across nanomolar to micromolar concentration windows depending on assay format and cellular context; in biomedical research workflows, this compound is typically applied in cell based mechanistic assays, phenotypic profiling, and comparator panels for central nervous system active scaffolds, and it may also be incorporated into animal model study designs focused on behavioral pharmacology and pathway perturbation, with the concentrations or doses used in experiments typically depending on specific experimental designs and research objectives.